Cell Bioprocess Engineering: Basic Fundamentals and Applications

Dear Colleagues,

Industrial Cell Culture to produce human biologics has progressed from a “dream” in the early 1980s to an estimated 19 billion dollar (USD) annual industry with a projected growth rate of 7 percent annually. Congruent with this financial growth is the productivity and scale and productivity of the cell culture processes.  As human biologics progress from specialty products to, potentially, near commodities, such as basic antibiotics, significant pressure will continue to build on further increase productivity and decrease operating costs.  This success in biologics has also contributed toward the prediction that cell therapy (i.e. cells are the product) and cultured meat are economically viable.  While the ongoing commercial success of biologics is the result of many scientific and technological advancements, large scale, economic cell culture has been vital, and is even more important for cell therapy and cultured meat.  In this collection of articles, we wish to highlight the key technological challenges, and progress addressing these issues not just in biologics production but also cell therapy and cultured meat. 

Since this is a special issues focused on Bioprocessing, obvious topics will be included, but not limited to: modes of operation of the bioprocess, cell densities and associated challenges, specialized media and associated costs, product/byproduct removal, and mixing including nutrient delivery.   

Prof. Dr. Jeffrey J. Chalmers
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.